SHELTON CAPITAL MANAGEMENT - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHELTON CAPITAL MANAGEMENT ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$222,785
+5.2%
2,4870.0%0.01%0.0%
Q2 2023$211,743
-2.6%
2,487
-5.3%
0.01%
-11.1%
Q1 2023$217,384
+5.2%
2,6270.0%0.01%
-59.1%
Q4 2022$206,614
-0.7%
2,627
-6.6%
0.02%
+120.0%
Q3 2022$208,000
-33.3%
2,8140.0%0.01%
-9.1%
Q1 2021$312,000
-11.1%
2,814
-4.7%
0.01%
-31.2%
Q4 2020$351,000
+36.0%
2,9530.0%0.02%
+45.5%
Q3 2020$258,000
-2.3%
2,9530.0%0.01%
-26.7%
Q2 2020$264,000
-14.8%
2,953
-4.9%
0.02%
-31.8%
Q1 2020$310,000
-18.2%
3,106
-5.9%
0.02%
+4.8%
Q4 2019$379,000
-13.1%
3,299
-4.7%
0.02%
-19.2%
Q3 2019$436,000
+4.8%
3,4600.0%0.03%
+8.3%
Q2 2019$416,000
-88.9%
3,460
+958.1%
0.02%
+60.0%
Q1 2019$3,739,000
+899.7%
327
-91.3%
0.02%
-40.0%
Q4 2018$374,000
-12.6%
3,7390.0%0.02%
+4.2%
Q3 2018$428,000
-7.2%
3,739
-27.3%
0.02%
-17.2%
Q2 2018$461,000
+22.6%
5,1440.0%0.03%
+16.0%
Q1 2018$376,000
+37.7%
5,144
+9.5%
0.02%
+38.9%
Q4 2017$273,000
+29.4%
4,6990.0%0.02%
+28.6%
Q3 2017$211,000
+3.4%
4,699
-9.0%
0.01%0.0%
Q2 2017$204,0005,1660.01%
Other shareholders
HAEMONETICS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders